Discovery of Deoxylimonin Δ-Lactam Derivative with Favorable Anti-Inflammation and Antinociception Efficacy from Chemical Modified Limonin/deoxylimonin Analogs.

Shaochi Wang,Xueqing Han,Yun Yang,Chen Zhou,Danmeng Luo,Wensong He,Qihua Zhu,Yungen Xu
DOI: https://doi.org/10.1016/j.bioorg.2020.103886
IF: 5.307
2020-01-01
Bioorganic Chemistry
Abstract:Chemical modifications on the A ring of limonin (1) and deoxylimonin (2) afforded 28 structural characterized derivatives, which were firstly subjected to preliminary in vivo analgesic and anti-inflammatory screen by mice model. The most promising candidate, deoxylimonin analog II-B-2 (70 mg/kg) with 3,4-dimethoxyphenylethyl moiety substitued δ-lactam in the A ring, exhibited better analgesic activity than aspirin (200 mg/kg) and stronger anti-inflammatory efficacy than naproxen (150 mg/kg). Further in vivo evaluation confirmed its advantage over limonin and showed dose-response dependent manner, and follow-up research suggested that the anti-inflammatory effect of compound II-B-2 may be attributed to the downregulation of cyclooxygenase 2 expression and the suppression of prostaglandin E2 formation.
What problem does this paper attempt to address?